7221 Cambridge Research Park
About OptibriumOptibrium provides elegant software solutions for small molecule design, optimisation and data analysis.
CEO: Matthew Segall
CSO: Edmund Champness
Please click here for Optibrium job opportunities.
Tweets by Optibrium
29 articles with Optibrium
10/16/2019Companies from across the globe provide business and pipeline updates.
Biotech and pharma companies from across Europe and Asia provide updates on pipeline and business activities.
2/1/2019As January ends, biotech and pharma companies tap new leaders to help drive strategic visions. New hires at Histogen, Indalo, Novartis Oncology, Calico, and more.
Optibrium™, a developer of software for drug discovery, today announced the appointment of Clare Devlin as Financial Director.
Provides students with the opportunity to design new drug-like molecules targeting fibrotic diseases and malaria with cutting-edge drug discovery software
Optibrium, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery
Optibrium today announced it has appointed Dr. Scott Lyon as Director of Business Development and relocated its Headquarters and R&D facilities, to Cambridge Innovation Park, Cambridge, UK.
Optibrium, Imperial College London And DNDi Collaborate In Drug Development Programme For Neglected Diseases
Optibrium And eMolecules, Inc. Release: Companies Collaborate On Chemistry Data Integration In StarDrop